Article
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome.
Haematologica - 1 Apr 2022
Todoerti Katia, Ronchetti Domenica, Favasuli Vanessa, Maura Francesco, Morabito Fortunato, Bolli Niccolò, Taiana Elisa, Neri Antonino
Abstract excerpt
DIS3 gene mutations occur in roughly 10% of patients with multiple myeloma (MM); furthermore, DIS3 expression can be affected by monosomy 13 and del(13q), which occur in approximately 40% of MM cases. Despite several reports on the prevalence of DIS3 mutations, their contribution to the pathobiology of MM remains largely unknown. We took advantage of the large public CoMMpass dataset to investigate the spectrum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
